SHOC2 p.Ser4Arg
c.10A>C · rs397517231 · VCV40635
ClinGen expert panel — RASopathy VCEP
Benign for RASopathy. Applied ACMG criteria (verbatim):
BP5 BP4 BA1
Curation rationale (ClinGen, verbatim)
The c.10A>C variant in the SHOC2 gene is a missense variant predicted to cause substitution of serine by arginine at amino acid 4 (p.Ser4Arg). The highest filtering allele frequency in gnomAD v4.1.0 is 0.2286% (124/59742 alleles) in the Admixed American population and therefore meets this criterion (BA1). The computational predictor tool REVEL gives a score of 0.113 and does not predict a damaging effect on SHOC2 function (BP4). This variant has been identified in a patient with an alternate molecular basis for disease (BP5; GeneDx, Partners LMM GTR Lab ID: 26957, 21766 internal data; ClinVar SCV000209046.7, SCV000062455.5). In summary, this variant meets criteria to be classified as benign for autosomal dominant RASopathies based on the ACMG/AMP criteria applied, as specified by the ClinGen RASopathy Variant Curation Expert Panel: BA1, BP4, BP5 (Specification Version 2.1, 09/17/2024)
ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.
Computational evidence
| Protein change | ||
| AlphaMissense | 0.3345 | likely benign |
|---|---|---|
| REVEL | 0.113 | moderately benign-leaning |
| SaProt | LLR -5.46 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | <0.2 | no splice effect predicted · four deltas, not one · how we know |
| Constraint at this position | ||
| Conservation | phyloP 9.3 | GERP 1.3, phastCons 1 |
| Regional constraint | o/e 0.83 | unconstrained · MANE · 376 bp · p 0.042 · regional, not allelic |
| Overall | ||
| CADD | 23.3 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Admixed Americangrpmax | 0.208% | 482 |
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,442 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- SHOC2
- Protein
- p.Ser4Arg
- Coding
- c.10A>C
- MANE Select
- NM_007373
- dbSNP
- rs397517231
- Type
- single nucleotide variant
- Location
- chr10:110964368 (GRCh38)
- Gene constraint
- LOEUF 0.201 · pLI 1.00 · ClinGen HI 0/3 (gnomAD)
- Structure
- AlphaFold pLDDT 88.00 · 13 PDB
- Residue 4
- the 'disordered' region
Similar variants
- SHOC2 p.Ser4Gly Uncertain significance ★ ⚠ same residue
- SHOC2 p.Ser4Asn Uncertain significance ★ ⚠ same residue
- SHOC2 p.Met173Ile Pathogenic ★★★ ⚠ same condition
- SHOC2 p.Ser2Gly Pathogenic ★★★ ⚠ same condition
- SHOC2 c.-1C>T Uncertain significance ★★★ same condition
- SHOC2 p.Tyr189Phe Uncertain significance ★★★ ⚠ same condition
- SHOC2 c.1423-7C>T Benign ★★★ same condition
- SHOC2 c.1540+8C>A Likely benign ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/shoc2-p-ser4arg (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown